Lipid profile in nonobese pregnant women with polycystic ovary syndrome: A prospective controlled clinical study

Steroids

Volumn 88, Issue , 2014, Pages 36-43

  Palomba, Stefano ^a   Falbo, Angela ^a   Chiossi, Giuseppe ^a   Muscogiuri, Giovanna ^b   Fornaciari, Eleonora ^a   Orio, Francesco ^c   Tolino, Achille ^b   Colao, Annamaria ^b   La Sala, Giovanni Battista ^a,d   Zullo, Fulvio ^e  

^a IRCCS   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Androgens; Insulin resistance; Lipids; Lipoproteins; PCOS; Pregnancy

Indexed keywords

ANDROGEN; CHOLESTEROL; GLUCOSE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PROSPECTIVE STUDY; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; BLOOD; PATHOPHYSIOLOGY; RISK;

ADULT; FEMALE; HUMANS; LIPIDS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RISK;

EID: 84904175859     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2014.06.005     Document Type: Article

References (51)

1. F. Orio, and S. Palomba Reproductive endocrinology: new guidelines for the diagnosis and treatment of PCOS Nat Rev Endocrinol 10 2014 130 132
2. R.A. Wild, M. Rizzo, S. Clifton, and E. Carmina Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis Fertil Steril 95 2011 1073 1079
3. E. Herrera, and H. Ortega-Senovilla Maternal lipid metabolism during normal pregnancy and its implications to fetal development Clin Lipidol 5 2010 899 911
4. T.G. Vrijkotte, N. Krukziener, B.A. Hutten, K.C. Vollebregt, M. van Eijsden, and M.B. Twickler Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD study J Clin Endocrinol Metab 97 2012 3917 3925
5. J.M. Catov, L.M. Bodnar, K.E. Kip, C. Hubel, R.B. Ness, and G. Harger et al. Early pregnancy lipid concentrations and spontaneous preterm birth Am J Obstet Gynecol 197 2007 610 617
6. R.J. Edison, K. Berg, A. Remaley, R. Kelley, C. Rotimi, and R.E. Stevenson et al. Adverse birth outcome among mothers with low serum cholesterol Pediatrics 120 2007 723 733 (Pubitemid 47549559)
7. M.R. Jan, R. Nazli, J. Shah, and T. Akhtar A study of lipoproteins in normal and pregnancy induced hypertensive women in tertiary care hospitals of the North West Frontier Province-Pakistan Hypertens Pregnancy 31 2012 292 299
8. S. Ziaei, K.M. Bonab, and A. Kazemnejad Serum lipid levels at 28-32 weeks gestation and hypertensive disorders Hypertens Pregnancy 25 2006 3 10
9. J.G. Ray, P. Diamond, G. Singh, and C.M. Bell Brief overview of maternal triglycerides as a risk factor for pre-eclampsia BJOG 113 2010 379 386
10. HAPO Study Cooperative Research Group1 B.E. Metzger, L.P. Lowe, A.R. Dyer, E.R. Trimble, U. Chaovarindr, and D.R. Coustan et al. Hyperglycemia and adverse pregnancy outcomes N Engl J Med 358 2008 1991 2002 (Pubitemid 351656454)
11. C.M. Boomsma, M.J. Eijkemans, E.G. Hughes, G.H. Visser, B.C. Fauser, and N.S. Macklon A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome Hum Reprod Update 12 2006 673 683 (Pubitemid 44605508)
12. K.A. Toulis, D.G. Goulis, E.M. Kolibianakis, C.A. Venetis, B.C. Tarlatzis, and I. Papadimas Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis Fertil Steril 92 2009 667 677
13. Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am J Obstet Gynecol 2011;204:558.e1-6.
14. J.Z. Qin, L.H. Pang, M.J. Li, X.J. Fan, R.D. Huang, and H.Y. Chen Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis Reprod Biol Endocrinol 11 2013 56
15. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
16. World Health Organisation. Geneva: WHO; 1995. Physical status: the use and interpretation of anthropometry.
17. S. Palomba, A. Falbo, T. Russo, L. Battista, A. Tolino, and F. Orio et al. Uterine blood flow in pregnant patients with polycystic ovary syndrome: relationships with clinical outcomes BJOG 117 2010 711 721
18. A. Falbo, M. Rocca, T. Russo, A. D'Ettore, A. Tolino, and F. Zullo et al. Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes J Ovarian Res 3 2010 23
19. S. Palomba, A. Falbo, G. Chiossi, F. Orio, A. Tolino, A. Colao, and G.B. La Sala et al. Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: a prospective controlled clinical study J Clin Endocrinol Metab 2014 jc20141214 [Epub ahead of print]
20. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
21. P.H. Ducluzeau, P. Cousin, E. Malvoisin, H. Bornet, H. Vidal, and M. Laville et al. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome J Clin Endocrinol Metab 88 2003 3626 3631 (Pubitemid 37034505)
22. J.E. Morley, P. Patrick, and H.M. Perry III Evaluation of assays available to measure free testosterone Metabolism 51 2002 554 559 (Pubitemid 34516507)
23. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultra centrifuge Clin Chem 18 1972 499 502
24. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2003;26:S103-5.
25. Brown MA, Lindheimer MD, de Swiet M, van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society of the Study of Hypertension in pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV. (Pubitemid 32672922)
26. S. Palomba, A. Falbo, T. Russo, A. Tolino, F. Orio, and F. Zullo Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes Fertil Steril 94 2010 1805 1811
27. T. Sir-Petermann, B. Echiburú, M.M. Maliqueo, N. Crisosto, F. Sánchez, and C. Hitschfeld et al. Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome Hum Reprod 22 2007 1830 1836 (Pubitemid 47062748)
28. P.J. Barter, H.B. Brewer Jr, M.J. Chapman, C.H. Hennekens, D.J. Rader, and A.R. Tall Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis Arterioscler Thromb Vasc Biol 23 2003 160 167 (Pubitemid 36231923)
29. M.R. Taskinen LDL-cholesterol, HDL-cholesterol or triglycerides-which is the culprit? Diabetes Res Clin Pract 61 2003 S19 S26
30. J.D. Brunzell, and A.F. Ayyobi Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus Am J Med 115 2003 24S 28S
31. A.D. Sniderman, T. Scantlebury, and K. Cianflone Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus Ann Intern Med 135 2001 447 459 (Pubitemid 32845869)
32. S.M. Haffner, R.S. Kushwaha, D.M. Foster, D. Applebaum-Bowden, and W.R. Hazzard Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy Metabolism 32 1983 413 420 (Pubitemid 13083599)
33. A.J. Owen, P.D. Roach, and M. Abbey Regulation of low-density lipoprotein receptor activity by estrogens and phytoestrogens in a HepG2 cell model Ann Nutr Metab 48 2004 269 275 (Pubitemid 39382387)
34. S. Von Eckardstein, A. von Eckardstein, H.G. Bender, H. Schulte, and G. Assmann Elevated low-density lipoprotein-cholesterol in women with polycystic ovary syndrome Gynecol Endocrinol 10 1996 311 318 (Pubitemid 26364670)
35. Ulmannova T, Bartaskova D, Spalova I, Zoban P, Vesely Z, Stechova K. Maternal BMI and HDL as predictors of pregnancy outcome in women with type 1 diabetes. J Matern Fetal Neonatal Med; 2014 Jan 6.
36. Charlton F, Tooher J, Rye KA, Hennessy A. Cardiovascular risk, lipids and pregnancy: preeclampsia and the risk of later life cardiovascular disease. Heart Lung Circ; 2013 Oct 29.
37. J. Puhkala, R. Luoto, M. Ahotupa, J. Raitanen, and T. Vasankari Postpartum weight retention is associated with elevated ratio of oxidized LDL lipids to HDL-cholesterol Lipids 48 2013 1227 1235
38. D.A. Enquobahrie, M.A. Williams, C.L. Butler, I.O. Frederick, R.S. Miller, and D.A. Luthy Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia Am J Hypertens 17 2004 574 581 (Pubitemid 38844983)
39. Palomba S, Falbo A, Chiossi G, Tolino A, Tucci L, La Sala GB, et al. Early trophoblast invasion and placentation in women with different polycystic ovary syndrome phenotypes. Reprod Biomed Online 2014. pii: S1472-6483(14)00244- 2. http://dx.doi.org/10.1016/j.rbmo.2014.04.010. [Epub ahead of print].
40. J.G. Ray, P. Diamond, G. Singh, and C.M. Bell Brief overview of maternal triglycerides as a risk factor for pre-eclampsia BJOG 113 2006 379 386
41. B. Lorentzen, M. Endresen, T. Clausen, and T. Henriksen Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia Hypertens Pregnancy 13 1994 103 109 (Pubitemid 24144729)
42. A. Ghio, A. Bertolotto, V. Resi, L. Volpe, and G. Di Cianni Triglyceride metabolism in pregnancy Adv Clin Chem 55 2011 133 153
43. A.M. Baker, R.L. Klein, K.L. Moss, S. Haeri, and K. Boggess Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia Am J Obstet Gynecol 201 2009 293 294
44. Catov JM, Bodnar LM, Kip KE, Hubel C, Ness RB, Harger G, et al. Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol 2007;197:610.e1-7.e1.
45. G. Boutzios, S. Livadas, C. Piperi, N. Vitoratos, C. Adamopoulos, and D. Hassiakos et al. Polycystic ovary syndrome offspring display increased oxidative stress markers comparable to gestational diabetes offspring Fertil Steril 99 2013 943 950
46. G.J. Burton, and E. Jauniaux Oxidative stress Best Pract Res Clin Obstet Gynecol 25 2011 287 299
47. C.A. Hubel Dyslipidemia, iron, and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions Semin Reprod Endocrinol 16 1998 75 92 (Pubitemid 28285306)
48. N. Sattar, J.R. Petrie, and A.J. Jaap The atherogenic lipoprotein phenotype and vascular endothelial dysfunction Atherosclerosis 138 1998 229 235 (Pubitemid 28313507)
49. B.H. Kandimalla, A. Sirjusingh, B.S. Nayak, and S.S. Maiya Early antenatal serum lipid levels and the risk of pre-eclampsia in Trinidad and Tobago Arch Physiol Biochem 117 2011 215 221
50. S. Palomba, T. Russo, A. Falbo, A. Di Cello, G. Amendola, and R. Mazza et al. Decidual endovascular trophoblast invasion in women with polycystic ovary syndrome: an experimental case-control study J Clin Endocrinol Metab 97 2012 2441 2449
51. S. Palomba, T. Russo, A. Falbo, A. Di Cello, A. Tolino, and L. Tucci et al. Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome Hum Reprod 28 2013 2838 2847